Leena Menghaney
See the following -
Ahead Of Obama Visit, MSF Warns US Pressure On India Could Impact Access To Medicines For Millions
Ahead of US President Obama’s visit to India, the international medical humanitarian organisation Medecins Sans Frontieres/ Doctors Without Borders (MSF) expressed deep concern over the US government’s heightened efforts to undermine access to affordable medicines from India—often called the ‘pharmacy of the developing world.’...
- Login to post comments
Funding Crunch Hits Neglected Diseases Plan
The Open Source Drug Discovery (OSDD) programme — a global collaborative initiative supported by the Indian government to find affordable treatment for neglected tropical diseases — has suffered a temporary setback due to a funds crunch caused by tardy submission of funding estimates. Read More »
- Login to post comments
India's Open Source Drug Discovery Program Faces Lack Of Funding
India's Open Source Drug Discovery Program, or OSDD, ran out of funding last week, as the ministry of science and technology did not clear the cabinet note to extend the project's funding on time. OSDD was created in 2008 in an effort to develop new drugs to treat neglected diseases, including Tuberculosis, Malaria, and Leishmaniasis.
- Login to post comments
Merck To Bristol-Myers Face Threats On India Patents (Correct)
Pharmaceutical companies from Merck & Co. (MRK:US) to Bristol-Myers Squibb Co. (BMY:US) face fresh threats to protecting their patents in India as a government-appointed panel prepares to evaluate more drugs for local makers to copy. The panel is looking beyond the cancer treatments it studied last year to areas such as HIV and diabetes, according to two people with knowledge of the matter, who asked not to be identified because the discussions are private.
- Login to post comments